SCHEMBL15537666

SCHEMBL15537666

CC(C)(F)CN1CCC(CNc2ccc(-c3ccc(C(=O)O)c(F)c3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 2/20 0.47
SSTR5 P35346 2/20 0.47
CHRM2 P08172 1/20 0.45
CHRM5 P08912 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
LTA4H P09960 1/20 0.40
RARB P10826 3/20 0.39
RARA P10276 2/20 0.39
RARG P13631 1/20 0.39
ACHE P22303 2/20 0.39
BACE1 P56817 2/20 0.39
LIPC P11150 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
DYRK1A Q13627 5/20 0.38
WNT1 P04628 2/20 0.38
GSK3B P49841 2/20 0.38
CARM1 Q86X55 1/20 0.38
PRMT6 Q96LA8 1/20 0.38
SCN9A Q15858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20053654 0.89 KCNH2 (0.41) CHRM4SSTR5CHRM2CHRM5CHRM1
SCHEMBL15539844 0.88 SSTR5 (0.44) CHRM4SSTR5CHRM2CHRM5CHRM1
SCHEMBL15538494 0.85 SSTR5 (0.53) CHRM4SSTR5CHRM2CHRM1LTA4H
SCHEMBL21535109 0.85 CHRM4 (0.37) CHRM4SSTR5CHRM2CHRM5CHRM1
SCHEMBL16803776 0.83 PREP (0.40) CHRM4SSTR5CHRM2CHRM5CHRM1
SCHEMBL15538445 0.82 RARA (0.51) CHRM4SSTR5CHRM2CHRM5CHRM1
SCHEMBL16803881 0.82 PARP1 (0.38) CHRM4
SCHEMBL15538448 0.80 CHRM4 (0.43) CHRM4SSTR5CHRM2CHRM5CHRM1
SCHEMBL15538434 0.79 CHRM4 (0.47) CHRM4SSTR5LTA4HACHEBACE1
SCHEMBL15537663 0.79 CHRM4 (0.42) CHRM4CHRM2CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 CHRM4 669/4885SSTR5 104/4885CHRM2 432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.